Marksans Pharma Ltd Quarterly Results

Gross Sales

681.85

641.92

590.62

560.01

586.13

Excise Duty

0

0

0

0

0

Net Sales

681.85

641.92

590.62

560.01

586.13

Other Operating Income

0

0

0

0

0

Other Income

27.85

11.06

14.95

16.53

4.8

Total Income

709.7

652.98

605.57

576.54

590.93

Total Expenditure

543.08

506.24

462.18

450.37

453.11

PBIDT

166.61

146.74

143.39

126.17

137.82

Interest

2.67

2.63

2.92

4.84

3.16

PBDT

163.95

144.11

140.46

121.33

134.66

Depreciation

20.69

19.51

20.44

21.06

22

Minority Interest Before NP

0

0

0

0

0

Tax

38.01

36.29

30.01

30.74

28.07

Deferred Tax

0.18

-9.45

0.94

-8.11

1.63

Reported Profit After Tax

105.07

97.76

89.07

77.64

82.97

Minority Interest After NP

0.5

1.04

0.32

-0.65

-0.27

Net Profit after Minority Interest

104.56

96.72

88.75

78.29

83.24

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

104.56

96.72

88.75

78.29

83.24

EPS (Unit Curr.)

2.31

2.13

1.96

1.73

1.84

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

45.32

45.32

45.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

24.43

22.85

24.27

22.52

23.51

PBDTM(%)

24.04

22.44

23.78

21.66

22.97

PATM(%)

15.4

15.22

15.08

13.86

14.15